MergerMay 4, 2026, 04:08 PM
Ekso Bionics Completes Business Combination, Renames to ChronoScale
AI Summary
Ekso Bionics Holdings, Inc. announced the consummation of its previously disclosed business combination transaction, effective May 5, 2026. In connection with this, the company will change its name to ChronoScale Corporation and its Nasdaq ticker symbol to "CHRN". Additionally, Ekso Bionics entered into a PIPE investment with Applied Digital Corporation, selling 1,311,407 shares for approximately $15.75 million.
Key Highlights
- Business combination with Applied Digital subsidiaries effective May 5, 2026.
- Company to rename to ChronoScale Corporation on May 5, 2026.
- Common Stock to trade as "CHRN" on Nasdaq from May 5, 2026.
- New CUSIP for Common Stock is 170924 104.
- Sold 1,311,407 shares in PIPE investment to Applied Parent at $12.01 per share.
- Raised approximately $15.75 million in gross proceeds from PIPE investment.
- Paid Lake Street Capital Markets a $0.75 million cash fee for placement services.
- Exchanged Shares and Private Placement Shares issued via unregistered sales.